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Introduction: Preconditioning by brief ischemia protects not only the concerned organ, but 
also other distant organs against subsequent lethal damage, called remote ischemic 
preconditioning (RIPC). This study was designed to investigate the impact of intestinal RIPC 
against hepatic ischemia/reperfusion injury (IRI), with special interests in heme oxygenase-1 
(HO-1) induction in the 2nd-window of protection (SWOP). 
Materials & Methods: Male Wistar rats were randomly assigned into 2 groups; Group-RIPC 
or Group-Sham. Prior to hepatic IRI, either intestinal RIPC, consisting of 2 cycles of 4-minute 
SMA clamping separated by 11-minute declamping (Group-RIPC), or sham procedure 
(Group-Sham), was performed. After 48-hour recovery, the rats were exposed to 30-minute 
total hepatic IRI. Transaminase releases and proinflammatory cytokines were determined at 
several time-points after reperfusion. Histopathological analysis and animal survival were 
also investigated. 
Results: Intestinal RIPC significantly lowered transaminase release (ALT at 2 hours, 
Group-RIPC vs. Group-Sham; 873.3±176.4 vs. 3378.7±871.1 IU/L; p<0.001), as well as 
proinflammatory cytokines production (TNF-α at 2 hours, 930±42 vs. 387±17 pg/µL; 
p<0.001). Morphological integrity of the liver and the ileum were significantly better 
maintained by intestinal RIPC, reaching to statistical significance not only in Suzuki’s liver 
injury score (3.5±0.2 vs. 0.7±0.5; p=0.0074) but in Park’s score for intestinal damages 
(4.0±0.4 vs. 2.0±0.2; p=0.0074). Animal survival was also markedly improved (83.1 vs. 
15.4%, p<0.001). As a mechanism underlying the protection, HO-1 was substantially induced 
in liver tissue, especially into hepatocytes, with remarkable up-regulation of bradykinin in the 
portal blood, while HO-1 protein induction in enterocytes was not significant. 
Conclusion: Intestinal RIPC remarkably attenuates hepatic IRI in the SWOP, presumably by 





 Ischemia reperfusion injury (IRI) is a pathophysiologic process where hypoxic organ 
damage is accentuated by following restoration of blood flow and oxygen delivery to the 
ischemically-damaged tissue. Then the liver is exposed not only to direct cellular damage 
from ischemic insult but also to delayed dysfunction and tissue injuries resulting from 
activation of inflammatory cascades after reperfusion (1). Hepatic IRI is often encountered in 
various clinical situations including liver transplantation, trauma, shock state followed by 
resuscitation, and elective liver resections with inflow occlusion that is frequently used to 
minimize blood loss.  
 Ischemic preconditioning (IPC) refers to a strategy in which prior transient ischemia 
induces a state of protection against subsequent prolonged damage (2). In hepatobiliary 
surgery, total hepatic inflow occlusion, termed as Pringle’s maneuver (3), represents an 
effective strategy to reduce blood loss and transfusion requirements (4). However, noble 
Pringle’s maneuver easily results in adverse effects, especially on marginal livers such as 
cirrhosis (5) and steatosis (6), because a safe ischemic period for normal liver might be 
conversely crucial for marginal livers to be yielded to liver failure (7). Same difficulties are in 
ischemic insults for preconditioning. To date, there has been several randomized, controlled 
clinical trials evaluating the efficacy of IPC in liver resections and transplantations, however, 
most of which failed to support clinical benefits of IPC despite various protective results from 
numerous experimental settings (8, 9). One of the major obstacles is thought to be in the 
difficulty to determine the ideal protocol of IPC in humans. In clinical practice, patients’ 
characteristics including systemic as well as hepatic conditions are quite different in each case. 
Ten minutes IPC seems to be beneficial for normal or less-damaged livers, whereas it might 
be harmful for cirrhotic patients. In other words, we could neither know the best IPC protocol 




“Blue liver” with liver metastasis from colorectal cancer. Alternatively, much attention has 
recently been paid to a novel method, remote organ preconditioning, in which a preceding 
stress to remote organ/tissue confers protection to the concerned organs (10-12). Actually, 
remote ischemic preconditioning (RIPC) to the hind-limb has been shown to exert substantial 
protection to hepatic IRI in several experimental studies (11, 12). Because RIPC is a 
recently-explored phenomenon, there has been little evidence about RIPC to the liver: Could 
splanchnic organs instead of hind-limb be the target for RIPC to the liver? ; Does RIPC also 
exhibit delayed-phase effect/ 2nd window of protection (SWOP) like IPC? 
 The beneficial effects of IPC and RIPC are, at least in part, associated with the 
induction of heat shock proteins, especially in the SWOP. Among them, heme oxygenase-1 
(HO-1) is induced in a variety of organs during diverse stress-related conditions, and exerts a 
cytoprotective function in hepatic IRI and liver transplantation (13, 14). However, less is 
known about the involvement and the impact of HO-1 induction to the liver in RIPC. 
  This study was thus designed to investigate whether intestinal IPC, as a RIPC to the 
liver, could provide protective effects against hepatic IRI, with special interests in the role of 
HO-1 induction both in liver and in intestinal tissues. In addition, we tried to provide possible 
mechanisms underlying distant HO-1 induction in liver tissue by RIPC, as well as the 









 All experimental protocols were approved by the Animal Research Committee of Kyoto 
University, and all animals received humane care according to Guide for the Care and Use of 
Laboratory Animals (National Institutes of Health Publicatioon No 86-23, revised, 1985). 
Male Wistar rats weighing 180-220 g were obtained from SLC (Shizuoka, Japan). The rats 
were kept in a temperature-controlled environment with a 12-hour light-dark cycle and 
allowed tap water and standard chow pellets ad libitum. During the last 12 hours before the 
experiments, the animals had no access to solid food but free access to water. 
1. Intestinal RIPC followed by THI 
1-1. Surgical Procedures 
 After an acclimatization period of 7 days, rats were randomly assigned into 2 groups (n 
= 18 each), Group-RIPC or Group-Sham. The rats in the both groups were anesthetized with 
Isoflurane (Escain®, Mylan, Osaka, Japan) via small animal anesthetizer (MK-A110, 
Muromachi Kikai Co., Ltd., Tokyo, Japan). The animals’ body temperature was maintained at 
36.5 ± 0.5°C with a heating pad (Midori shokai, Hiroshima, Japan).  
 First, laparotomy was performed through a midline incision, and superior mesenteric 
artery (SMA) was exposed. Free peritoneum was covered with a plastic wrap (Saran Wrap®, 
Asahi Kasei, Tokyo, Japan) to minimize evaporative heat and fluid loss. In Group-RIPC, 
intestinal RIPC, consisting of 2 cycles of 4-minute SMA clamping with an atraumatic vessel 
clip (Sugita clip, Mizuho Co., Ltd, Tokyo, Japan) separated by 11-minute reperfusion, was 
performed, while the rats in Group-Sham SMA received sham procedure without any 
clamping maneuver. Abdominal wall was then closed.  
 After 48-hour recovery, the rats in both groups were exposed to total hepatic ischemia 




Japan) was inserted into the penile vein, enabling continuous infusion of 3 ml/kg/hr of 
Ringer’s solution. After laparotomy, the portal vein and the proper hepatic artery were both 
occluded by the aforementioned clip. After 30 minutes of THI, the clip was removed and the 
liver was reperfused. Abdominal wall was closed again to allow transient recovery from the 
operation. After 2, 6, and 24 hours from reperfusion, the rats were re-anesthetized, and both 
portal venous and peripheral blood, liver and ileal tissue samples were collected (Fig. 1A). A 
half of tissue samples was immediately frozen in liquid nitrogen and stored at -80°C until 
later analysis, and the other half was embedded in 4% paraformaldehyde for histopathological 
evaluation. 
1-2. Measurement of Liver Enzymes 
 Serum concentrations of aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), and lactate dehydrogenase (LDH) were measured by a standard specrtrophotometric 
method with an automated clinical analyzer (JCA-BM9030, JEOL Ltd., Tokyo, Japan). 
1-3. Evaluation of cytokines production 
 Serum concentration of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and 
IL-10 were determined by using BD Cytometric Bead Array Rat Flex Set (Cat; 558308, 
558309, and 558306, respectively, Becton, Dickinson and Company Japan, Tokyo, Japan) 
according to the manufacture’s protocol. Flow cytometry analysis was carried out in a FACS 
Calibur flow cytometer (Becton Dickinson and Company Japan, Tokyo, Japan). 
1-4. Histopathological Assessment 
 Ileal and hepatic tissues were fixed with 4% paraformaldehyde, embedded in paraffin 
wax and sectioned at 4µm thickness. The slides were then stained with hematoxylin and eosin. 
Three pathologists assessed and scored ileal and hepatic tissue damage in a blind fashion, 
according to Suzuki’s classification for hepatic injury (15) and to Park’s score for intestinal 




1-5. Scanning Electron Microscopy 
 With respect to liver samples for electron microscopy, we first perfused rats with saline 
through the aorta and then with a fixative containing 2% glutaraldehyde and 4% 
paraformaldehyde. The livers were cut into larger pieces (5 mm3) and postfixed in 2% 
glutaraldehyde and 4% paraformaldehyde at 4°C for 2 hours. Each sample was ion-sputter- 
coated and observed with a S-4700 scanning electron microscope (Hitachi, Ltd., Tokyo, 
Japan). 
1-6. Survival Study 
 Animal survival was also investigated as an end-point parameter for the efficacy of the 
treatment. For this purpose, additional 13 rats in each group were subjected to 35-minute THI 
by Pringle’s maneuver that is thought to be almost lethal for rats. After the operation, all rats 
were carefully observed up to 10 days. 
 
2. Intestinal RIPC without hepatic IRI 
 To investigate the effect of RIPC with a special interest in HO-1 induction to the liver 
and the gut, additional rats (n = 30 in each group) were prepared, and subjected to either 
intestinal RIPC or sham procedure, without hepatic IRI. Blood and tissue samples from liver 
and ileum were obtained at 2, 6, 24, 72 and 168 hours after RIPC/sham procedure (Fig. 1B). 
2-1. Liver Damage after intestinal RIPC 
 To evaluate the influence of intestinal RIPC to the liver, serum AST and ALT were 
measured after intestinal RIPC in the absence of liver IRI by the same manner. 
2-2. Reverse-Transcriptase Polymerase Chain Reaction 
 To analyze the chronological alteration of the gene expression in the liver and the 
intestinal tissue, total RNA of the both tissues was extracted with TRIzol® (Life 




amounts of RNA were adjusted using NanoDrop2000® (NanoDrop Technologies, 
Wilmington, Delaware, USA) and complementary DNA was reverse-transcribed by 
incubation with Omniscript RT Kit (Qiagen, Tokyo, Japan) according to the manufacture’s 
protocol. Real-time PCR was performed using TaqMan® technology and the real-time PCR 
system (StepOnePlus®, Life Technologies Japan, Tokyo, Japan). TaqMan® probe and 
primers for TNF-α (assay ID Rn99999017_m1), IL-6 (assay ID Rn01410330_m1), and HO-1 
(assay ID Rn01536933_m1), and β-actin (assay ID Rn00667869_m1) were obtained from 
TaqMan® gene expression assays (Applied Biosystems, Life Technologies Japan, Tokyo, 
Japan).  
2-3. Western Blot Analysis 
 Tissue samples were homogenized in lysis buffer containing 50 mM Tris-HCl (pH 6.8), 
10% glycerol, and 2% sodium dodecylsulfate. Protein quantification of samples was 
performed with bicinchoninic acid protein assay. Detergent-soluble protein lysates were 
separated by SDS-polyaclylamidegel electrophoresis on a 12.5% acrylamide gel, and proteins 
were transferred onto polyvinylidene difluoride membranes. The membranes were blocked 
with Blocking One (Nacalai Tesque, Kyoto, Japan) and incubated with a primary antibody 
recognizing HO-1 (SPA-896; Stressgene, Victoria, Canada), or β-actin (KO0305, Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) at 1:1000 dilution overnight at 4°C. After washing, 
membranes were reacted with horseradish peroxidase-conjugated antibodies (Santa Cruz 
Biotechnology Inc., Santa Cruz, CA). Chemiluminescence was detected with immobilon 
western horseradish peroxidase substrate (Millipore, Billerica, MA.) and visualized with a 
charge-coupled device camera (Ez-capture, Atto Corporation, Tokyo, Japan). The intensity of 






 For immunohistochemistry of HO-1, paraffin sections were pretreated with 0.3% 
H2O2 in methanol and then subjected to antigen retrieval in citrate buffer (10 mM, pH 6.0) in 
a pressure cooker. After blocking with 3% bovine serum albumin-10% normal serum for 1 
hour, the sections were incubated with the above-mentioned aniti-HO-1 antibody at 1:200 
dilution overnight at 4°C. Subsequently, the sections were incubated with Labeled Polymer in 
an Envision + System HRP Kit (Dako, Tokyo, Japan) at room temperature for 1 hour. The 
sections were then examined with a Liquid DAB Substrate Chromogen System (Dako, Tokyo, 
Japan). 
2-5. Bradykinin Measurment after intestinal RIPC, compared with hindlimb RIPC 
In order to investigate what signals are transduced from the preconditioned intestine 
into the liver, we measured serum concentration of bradykinin, one of the central humoral 
mediators in RIPC [ref.1], both in the portal and in systemic blood, according to the 
manufacture’s protocol (#ADI-900-206, Enzo Life Sciences AG, Switzerland). To assess the 
advantage of intestinal RIPC compared with hindlimb RIPC that was the only method ever 
reported to be effective against hepatic IRI, additional rats were exposed to either intestinal or 
hindlimb RIPC (n=6 each). The regimens used here were both 2 cycles of 4-minute clamping 
and 11-minute relief of either SMA or right femoral artery, respectively. 
 
Statistical Analysis 
 All results are expressed as means ± standard error of mean (SEM), unless otherwise 
indicated. Two-way repeated-measurement analysis of variance (ANOVA) followed by 
Bonferroni’s post-test was used to assess the time-dependent parameters between the groups. 
Animal survival was assessed by the Kaplan-Meier method followed by a log-rank test. The 
other comparisons were performed by two-tailed Student’s t-tests/Mann-Whitney test 




Version 5.0c (GraphPad Software Inc., CA, USA). P-values less than 0.05 were considered 







Serum transaminase release after THI 
 To determine whether intestinal RIPC could attenuate hepatic IRI, we measured serum 
transaminase releases at 2, 6, and 24 hours after reperfusion. As shown in Figure-2A, AST 
was significantly lower in Group-RIPC (p=0.0005 between the groups by 2-way repeated 
measurement ANOVA: time-point assessment, Group-Sham vs. Group-RIPC; 5393.3 ± 
1517.7 vs. 1130.7 ± 216.6 IU/L; p<0.001 by posttest at 2 hours). Intestinal RIPC significantly 
reduced ALT (Fig. 2B: p<0.0001 between the groups, Posttest at 2 hours; Group-Sham vs.. 
Group-RIPC; 3378.7 ± 871.1 vs. 873.3 ± 176.4 IU/L; p<0.001, Posttest at 6 hours; 
Group-Sham vs. Group-RIPC; 2245.8 ± 321.0 vs. 426.8 ± 67.9 IU/L; p<0.01). Similar data 
were obtained also in LDH release (Fig. 2C: p=0.0102 by 2-way ANOVA, Posttest at 2hours; 
Group-Sham vs. Group-RIPC; 29990.2 ± 9838.7 vs. 7981.7 ± 1733.2 IU/L; p<0.01). 
Serum cytokine release after THI 
 Serum inflammatory cytokines release of IL-6 (Fig. 3A) and TNF-α (Fig. 3B), and 
anti-inflammatory mediator, IL-10 (Fig. 3C) were measured at 2, 6 and 24 hours after 
reperfusion. Intestinal RIPC significantly reduced both IL-6 (p=0.0347 by 2-way ANOVA, 
Posttest at 2 hours; Group-Sham vs. Group-RIPC; 1998 ± 775 vs. 562 ± 117 pg/µL; p<0.05) 
and TNF-α (p<0.0001, Posttest at 2 hours, Group-Sham vs. Group-RIPC; 930 ± 42 vs. 387 ± 
17 pg/µL; p<0.001). Of note, anti-inflammatory IL-10 elevation was also attenuated by 
intestinal RIPC compared with Group-Sham (p<0.0065, Posttest at 2 hours, Group-Sham vs. 
Group-RIPC; 11942 ± 3448 vs. 2248 ± 404 pg/µL; p<0.001)  
Tissue cytokine expression after THI 
 In order to reveal when and where inflammatory cytokines burst was attenuated by 
intestinal RIPC, we then quantified relative IL-6 (Fig. 4A, 4C) and TNF-α (Fig. 4B, 4D) 




Intestinal RIPC significantly lowered hepatic TNF-α release (p<0.0019, Posttest at 2 hours, 
Group-Sham vs. Group-RIPC; 7.90 ± 0.67 vs. 1.98 ± 0.64 relative value; p<0.001). Although 
the standard deviation is too large to reach statistical significance (p=0.14), IL-6 in liver tissue 
also showed same tendency. In contrast, intestinal RIPC had no influence on both IL-6 
(p=0.75) and TNF-α expression (p=0.35) in intestinal tissues. These results indicate that 
intestinal RIPC significantly alleviates proinflammatory cytokines production in the liver, but 
failed to attenuate inflammatory response from the gut. 
Histopathological Analysis and Tissue Damage Scores 
 Tissue sections of the liver and the ileum at 2 hours after reperfusion were evaluated 
histopathologically, and their tissue damages were quantified by using the scoring systems. 
The ileum in Group-Sham showed mucosal bleeding, denuded villi and loss of villus tissue 
(Fig. 5A), whereas in Group-RIPC, intestinal mucosa could maintain subepithelial space at 
villi, and displayed almost normal mucosal construction (Fig. 5B). Thus, Park’s injury score 
in Group-RIPC (Fig. 5C), 2.0 ± 0.2, was significantly lower than 4.0 ± 0.4 in Group-Sham 
(p=0.0074). Liver tissues in Group-Sham exhibited cytoplasmic vacuolization, sinusoidal 
congestion, and massive cellular infiltration (Fig. 5D), while in Group-RIPC, these damages 
were substantially alleviated (Fig. 5E), reaching to statistical significance in Suzuki’s criteria, 
as summarized in Fig. 5F (3.5 ± 0.2 vs. 0.7 ± 0.5; p=0.0074).  
Ultrastructural Analysis using Electron Microscopy 
 Hepatic microstructure at 2 hours after reperfusion was evaluated by means of scanning 
electron microscopy. In Group-Sham, destroyed and enlarged sinusoidal pores were observed 
(Fig. 5G), whereas sinusoidal wall structure was well preserved in Group-RIPC (Fig. 5H). 
Animal Survival 
There were neither postoperative complications nor mortality until sacrifice. None of 




 In lethal THI for 35 minutes, the 10-day survival in Group-Sham was just 15.4%, and 
all deaths occurred within 12 hours after reperfusion. In contrast, animal survival was 
remarkably improved by intestinal RIPC up to 83.1% (p<0.001, Fig. 6). 
Serum transaminase release after intestinal RIPC 
 As documented in the supplemental figure, our regimen of intestinal RIPC did not 
promote liver damage. The highest value of serum ALT was just 70 IU/L at 6 hours of 
reperfusion, which is thought to be much lower than by direct IPC to the liver. 
Chronological analysis of HO-1 induction by intestinal RIPC 
 The time course of HO-1 mRNA and protein expression in the both tissues was 
summarized in Fig.-7 and -8, respectively. As shown in Fig. 7A, intestinal RIPC significantly 
up-regulated HO-1 mRNA in liver tissue, up to 7-folds increase compared with Group-sham, 
at just 2 hours after the preconditioning. Thereafter, the expression gradually decreased, and 
returned to the level of the controls by 24 hours. In good agreement with the time-course of 
mRNA expression, HO-1 protein induction in liver tissue peaked at 6 to 48 hours after RIPC, 
then returning to the control level by 7 days (Fig.8A). In contrast to the liver, HO-1 mRNA 
expression in intestinal tissue was relatively low. Although mRNA expression reached 
statistical significance because of very small standard deviations (Fig.7B), it was not enough 
to drive significant induction of HO-1 protein to the intestine, as shown in Fig.8B. 
The site of HO-1 induction evaluated by immunohistochemistry 
 To detail the localization of HO-1 induction, we performed immunohistochemical 
staining of HO-1 of the both tissues at 48 hours after intestinal RIPC. In accordance with the 
Western-blots, no significant difference in HO-1 staining could be observed in ileal mucosa 
between the groups (Fig. 9A, 9B), affirming that our regimen of intestinal preconditioning 
failed to induce HO-1 substantially to intestinal epithelium. Meanwhile in the liver, Kupffer 




expression of HO-1 therein. However, Kupffer cells’ staining in Group-RIPC was more 
intense than in Group-C. Moreover, it is noteworthy that HO-1-stained granules in 
hepatocytes spread all over the lobule in Group-RIPC (Fig. 9D), indicating that intestinal 
RIPC could promote significant induction of HO-1 into hepatocytes. 
Signal transduction in intestinal RIPC, compared with hindlimb preconditioning 
 As shown in Fig.10, intestinal RIPC significantly up-regulated bradykinin release into 
the portal blood than by hindlimb RIPC (p<0.05). In systemic blood, however, no difference 
of bradykinin concentration was observed between the 2 methods. Taken together, these 
results suggest that intestinal RIPC promotes the direct inflow of bradykinin signals into the 







 This is the first report demonstrating that splanchnic organs, such as intestine, could be 
the target of RIPC to hepatic IRI, as well as that RIPC also exhibits SWOP like IPC, by 
means of stress proteins induction. In this study, we demonstrated the significant protection of 
both liver and intestine against total hepatic IRI, as evidenced by a) less hepatocellular 
damage verified by reduced transaminase release; b) attenuation of proinflammatory 
cytokines releases of TNF-α, IL-6, and IL-10 after THI; c) better-preserved tissue integrity 
both of the liver and of the intestine; and d) markedly improved animal survival in a lethal 
model of THI. 
 Clinically, hepatic IRI has been shown to correlate with poor outcomes after major 
hepatectomy and liver transplantation (17). Numerous and various attempts have been made 
so far, aiming at attenuating liver injury following prolonged periods of vascular occlusion, or 
of cold storage of liver grafts. Number of studies have demonstrated that HO-1 plays a 
protective role on liver IRI (18), also in the protection by IPC (19) and RIPC (12, 20). Under 
the physiological condition, HO-1 in the liver tissue was observed only in the 
non-parenchymal Kupffer cells (21), and various stressors have been shown to induce HO-1 
in hepatocytes (22). Recently HO-1 was reported to ameliorate hepatic IRI by suppressing 
proinflammatory cytokines release via inactivation of Kupffer cells (23). In the early phase of 
reperfusion, Kupffer cell activation is thought to occur first, giving rise to endothelial 
activation and dysfunction. Such responses by Kupffer cells to various stimuli seem to be 
biphasic, initiated by secretion of pro-inflammatory cytokines such as TNF-α, IFN-β, IL-6, 
and IL-1, followed by subsequent release of anti-inflammatory mediators, such as IL-10 (24).  
In the present study, TNF-α and IL-6 were both significantly down-regulated in Group-RIPC, 
and subsequent up-regulation of IL-10 was also attenuated, representing the inactivation of 




hepatocytes, which certainly contributed to attenuate parenchymal damage on liver IRI. 
Taken together, HO-1 up-regulation in Kupffer cells and massive induction of HO-1 in 
hepatocytes cooperate with each other, thus leading to alleviation of liver IRI. 
 As a consequence of intestinal ischemic preconditioning, intestinal damages after THI 
were remarkably attenuated, despite HO-1 protein induction in intestinal tissue was not 
significant. In the meanwhile, there have been several reports demonstrating that intestinal 
IPC induces HO-1 in intestinal tissue and mucosa (20, 25). This contradiction of HO-1 
induction may be due to the difference of the protocols used for preconditioning. Most of 
previous studies using SMA clamping adopted the protocol of 15-minute ischemia followed 
by 5 to 30 minutes of reperfusion (26), which was longer ischemic insult compared with the 
current study. Liver anatomically locates just the down-stream of intestine in portal 
circulation. In THI, portal triad clamping results in congestion of the splanchnic organs, 
which, in turn, damages up-stream organs including the gut. As documented in Fig.5, livers in 
Group-Sham were more damaged by IRI with a loss of sinusoidal endothelial cell integrity 
and subsequent disruption of the microcirculatory blood flow (27). Regarding the fact that 
impaired ileal mucosa after THI results from the disturbance of portal circulation, 
maintenance of the tissue integrity of hepatic microstructures in Group-RIPC certainly 
contributes to attenuate intestinal damages. 
 As for the regimen of intestinal RIPC, we adopted 2 cycles of 4-minute SMA 
clamping separated by 11-minute reperfusion, because of the following 3 reasons: 
1. Repeated ischemia has been proven to induce stronger protective effect than single 
ischemia (28). As a preliminary study, we tested 3 patterns of intestinal RIPC against liver 
IRI: 2 cycles of 2-, 4-, and 6-minute SMA clamping. Liver injury tended to be more alleviated 




2. We would like to avoid the direct ischemic insult to the liver occurred secondary to 
the reduction in portal perfusion by longer SMA clamping. As a preliminary observation, we 
measured the alteration of hepatic and intestinal perfusion during intestinal RIPC, by using 
laser Doppler flowmetry. By SMA clamping, intestinal (ileal) perfusion immediately fell 
down to 10-15% of pre-clamping value, however, total hepatic perfusion was maintained over 
75-80% of pre-clamping value (not significant reduction). This phenomenon seems to be 
attributed to a well-known endogenous response, hepatic arterial buffer response (HABR), 
which immediately functions to maintain total hepatic blood flow by increasing arterial flow 
when portal perfusion decreases. 
3. We think RIPC to the liver per se should not be harmful to the liver. As shown in 
the supplemental data, our regimen of intestinal RIPC did not promote liver damage. The 
highest value of serum ALT after the preconditioning was just 70 IU/L at 6 hours of 
reperfusion, which is thought to be much lower than by direct IPC to the liver. 
There have been a few reports describing RIPC against liver IRI, but all of which 
adopt the hindlimb ischemia as the site for RIPC (11, 12). Advantage of our regimen is the 
site exposed to preceding ischemia and shorter ischemic stress. Although the precise 
mechanisms have not been fully elucidated, by which the stimuli are transmitted from the 
preconditioned tissue to the target organs, both neural and humoral pathways are thought to 
be involved (29). Though ischemic periods shorter than 5 minutes or longer than 15 minutes 
are reported to fail to promote protection (30-32), our protocol strongly protects the liver as 
well as the intestine from THI-induced tissue damage. As a reason for this, we have revealed 
that our regimen of intestinal RIPC significantly amplified the bradykinin signal directly into 
the hepatic inflow, one of the central humoral mediators in RIPC [ref.1]. This, in turn, 
undoubtedly promotes endothelial NOS (nitric oxide synthase) activation, provoking NO 




of stress response. It is also noteworthy that the bradykinin signal in systemic blood was not 
different between these 2 different methods. In view of the fact that the gut is anatomically 
situated in immediate up-stream to the liver in portal circulation, even a little signal/stimulus 
certainly affect to just the down-stream organ, liver. 
Our results indicate that the protective effects by intestinal RIPC are presumably 
related to HO-1 induction. Numerous animal studies describing HO-1 administer zinc 
protoporphyrin-9 (ZnPP), to inhibit HO-1 activity and to prove the contribution of HO-1(20). 
However, ZnPP abolish not only induced HO-1 but also constitutively expressed HO-2 in 
hepatocytes. Hepatocelular HO-2 plays a pivotal role to lower vascular resistance of hepatic 
parenchyma, and to maintain sinusoidal circulation physiologically (21, 33, 34). Because 
ZnPP is just a competitive inhibitor to all isoforms of HO, we assume the administration of 
ZnPP might disrupt the physiological condition of the sinusoidal, portal circulation (33, 34).  
In conclusion, RIPC produced by repeated brief intestinal ischemia exerts 
substantial protection not only against liver IRI but also to the intestinal damage due to THI. 
The RIPC protocol of 2 cycles of 4-minute intestinal ischemia separated by 11-minute 
reperfusion induces substantial amount of HO-1 to the liver, thereby confers the significant 
protection as SWOP in RIPC. Although methods to identify and modify these protective 
pathways are areas of intense investigation, further studies extrapolating the mechanisms of 
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Legends for Figures: 
Figure 1. (A) Experimental protocol for studying the effect of intestinal remote ischemic 
preconditioning (RIPC) against total hepatic ischemia (THI). Rats were subjected either to 
sham operation or to intestinal RIPC, consisting of 2 cycles of 4 minutes of superior 
mesenteric arterial clamping separated by 11 minutes of declamping/reperfusion. 
(B) Experimental protocol for evaluating heme oxygenase-1 (HO-1) induction by intestinal 
RIPC. Rats were subjected either to sham operation or to intestinal RIPC without hepatic 
ischemia. 
In the both protocols, blood, liver and ileal tissue samples were obtained at indicated 
time-points. 
 
Figure 2. Serum (A) aspartate aminotransferase (AST), (B) alanine aminotransferase (ALT), 
and (C) lactate dehydrogenase (LDH) release after THI in sham operated rats (Group-Sham, n 
= 6) and in intestinal RIPC rats (Group-RIPC, n = 6). All data are presented as mean ± 
standard error of the mean (SEM). Two-way analysis of variance (2-way ANOVA) was used 
to assess intergroup difference, followed by Bonferroni’s post-test, if appropriate, to analyze 
the difference at each time-point. *: p < 0.001, †: p < 0.01, and ‡: p < 0.05 vs. Group-Sham in 
post-test, respectively. 
 
Figure 3. Serum (A) interleukin-6 (IL-6), (B) tumor necrosis factor-alpha (TNF-α), and (C) 
interleukin-10 (IL-10) release after total hepatic ischemia in Group-Sham, and in Group-RIPC, 
(n = 6 each). All data represent as mean ± SEM. Two-way ANOVA was used to assess 
intergroup difference, followed by Bonferroni’s post-test, if appropriate, to analyze the 






Figure 4. Chronological analysis of relative interleukin-6 (IL-6) and tumor necrosis 
factor-alpha (TNF-α) mRNA expression in liver tissues (Fig-4A and -4B, respectively), and 
in ileal tissues (Fig-4C and - 4D, respectively) after THI in Group-Sham and in Group-RIPC 
(n = 6 each). All data are presented as mean ± SEM, analyzed by 2-way ANOVA, followed 
by Bonferroni’s post-test. *: p < 0.001, †: p < 0.01, and ‡: p < 0.05 vs. Group-Sham in 
post-test, respectively. 
 
Figure 5. Representative tissue sections of the ileum (A and B) and the hepatic acini (D and 
E) after 2 hours of reperfusion, stained with hematoxylin and eosin. Intestinal and hepatic 
damage after THI were quantified by using Park’s (Fig 5C) and Suzuki’s (Fig 5F) scoring 
system, respectively (n = 6 each), represented by box-and-whiskers plot. The boxes represent 
the 25% to 75%, the whiskers represent the data range, and the lines in the box are given as 
the median values of the distribution. †: p < 0.01 vs. Group-Sham. Black bars indicate 100 
µm. 
Photomicrographs of the representative tissue sections by scanning electron microscopy, 
displaying the sinusoidal wall structures in Group-Sham (Fig. 5G) and Group-RIPC (Fig. 5H). 
The original magnification was x 8,000. 
 
Figure 6. Animal survival in the Group-Sham (gray line) and Group-RIPC (black line) in the 
prolonged ischemic time of 35-minute THI (n = 13 each). The probabilities of survival in 






Figure 7. Chronological analysis of heme oxygenase-1 (HO-1) gene expression in liver tissues 
(Fig. 7A) and in ileal tissues (Fig. 7B) after intestinal ischemic preconditioning (Group-RIPC) 
or sham operation (Group-Sham) by Real-Time Polymerase Chain Reaction (n = 6 each). 
β-actin was used as internal control. All data are presented as mean ± SEM, analyzed by 
2-way ANOVA, followed by Bonferroni’s posttest. *: p < 0.001, †:  p < 0.01, and ‡: p < 
0.05 vs. Group-Sham in posttests, respectively.  
 
Figure 8. Chronological analysis of heme oxygenase-1 (HO-1) protein induction in liver 
tissues (Fig. 8A) and in ileal tissues (Fig. 8B) after intestinal ischemic preconditioning 
(Group-RIPC) and sham operation (Group-Sham) by Western Bolts (n = 6 each). β-actin was 
used as internal control. All data represent mean ± SEM, analyzed by 2-way ANOVA, 
followed by Bonferroni’s posttest. *: p < 0.001, †:  p < 0.01, and ‡: p < 0.05 vs. Group-Sham 
in posttests, respectively.  
 
Figure 9. Immunohistochemistry of HO-1 in ileal (A, B) and liver (C, D) tissues in 
Group-Sham and Group-RIPC. Arrowheads (C, D) show HO-1 stained Kupffer cells and 
arrows (D) point HO-1 stained granules in hepatocytes. Black bars show length of 25 µm. 
 
Figure 10. Serum concentration of bradykinin both in portal and in systemic blood after either 
intestinal or hindlimb RIPC (n=6 each). The preconditioning regimens used here were both 2 
cycles of 4-minute clamping, separated by 11-minute relief of either SMA or right femoral 
artery, respectively. ‡: p < 0.05 vs. Systemic in intestinal RIPC, and Portal in hindlimb RIPC 
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